The invention provides pyrido[2,3-d]pyrimidin-7(8H)-one telomerase inhibitors of the formula ##STR1##

where R1, R2 are as defined herein. The invention also provides methods for preparing the compounds of formula I, methods of using the compounds to treat diseases such as cancer, and pharmaceutical compositions comprising the compounds.